| Product Code: ETC11227051 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Type 1 Diabetes Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Type 1 Diabetes Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Type 1 Diabetes Market - Industry Life Cycle |
3.4 Sweden Type 1 Diabetes Market - Porter's Five Forces |
3.5 Sweden Type 1 Diabetes Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Type 1 Diabetes Market Revenues & Volume Share, By Treatment Approach, 2021 & 2031F |
3.7 Sweden Type 1 Diabetes Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Sweden Type 1 Diabetes Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Sweden Type 1 Diabetes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of type 1 diabetes in Sweden |
4.2.2 Technological advancements in diabetes management devices |
4.2.3 Growing awareness about the importance of early diagnosis and treatment of type 1 diabetes |
4.3 Market Restraints |
4.3.1 High cost associated with diabetes management and treatment |
4.3.2 Limited access to specialized healthcare services for type 1 diabetes patients in certain regions |
5 Sweden Type 1 Diabetes Market Trends |
6 Sweden Type 1 Diabetes Market, By Types |
6.1 Sweden Type 1 Diabetes Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Type 1 Diabetes Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Sweden Type 1 Diabetes Market Revenues & Volume, By Insulin Therapy, 2021 - 2031F |
6.1.4 Sweden Type 1 Diabetes Market Revenues & Volume, By Blood Glucose Monitoring, 2021 - 2031F |
6.1.5 Sweden Type 1 Diabetes Market Revenues & Volume, By Artificial Pancreas, 2021 - 2031F |
6.1.6 Sweden Type 1 Diabetes Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2 Sweden Type 1 Diabetes Market, By Treatment Approach |
6.2.1 Overview and Analysis |
6.2.2 Sweden Type 1 Diabetes Market Revenues & Volume, By Rapid-Acting, 2021 - 2031F |
6.2.3 Sweden Type 1 Diabetes Market Revenues & Volume, By Continuous Monitoring, 2021 - 2031F |
6.2.4 Sweden Type 1 Diabetes Market Revenues & Volume, By Closed-Loop System, 2021 - 2031F |
6.2.5 Sweden Type 1 Diabetes Market Revenues & Volume, By Beta Cell Regeneration, 2021 - 2031F |
6.3 Sweden Type 1 Diabetes Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Sweden Type 1 Diabetes Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Sweden Type 1 Diabetes Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Sweden Type 1 Diabetes Market Revenues & Volume, By Home Care, 2021 - 2031F |
6.3.5 Sweden Type 1 Diabetes Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.4 Sweden Type 1 Diabetes Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Sweden Type 1 Diabetes Market Revenues & Volume, By Patients, 2021 - 2031F |
6.4.3 Sweden Type 1 Diabetes Market Revenues & Volume, By Healthcare Professionals, 2021 - 2031F |
6.4.4 Sweden Type 1 Diabetes Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 Sweden Type 1 Diabetes Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
7 Sweden Type 1 Diabetes Market Import-Export Trade Statistics |
7.1 Sweden Type 1 Diabetes Market Export to Major Countries |
7.2 Sweden Type 1 Diabetes Market Imports from Major Countries |
8 Sweden Type 1 Diabetes Market Key Performance Indicators |
8.1 Average age of diagnosis of type 1 diabetes in Sweden |
8.2 Adoption rate of continuous glucose monitoring (CGM) devices among type 1 diabetes patients |
8.3 Percentage of type 1 diabetes patients achieving target HbA1c levels |
9 Sweden Type 1 Diabetes Market - Opportunity Assessment |
9.1 Sweden Type 1 Diabetes Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Type 1 Diabetes Market Opportunity Assessment, By Treatment Approach, 2021 & 2031F |
9.3 Sweden Type 1 Diabetes Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Sweden Type 1 Diabetes Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Sweden Type 1 Diabetes Market - Competitive Landscape |
10.1 Sweden Type 1 Diabetes Market Revenue Share, By Companies, 2024 |
10.2 Sweden Type 1 Diabetes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here